Provenance du réseau au premier degré de Ji-Hoon Park
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
TeraImmune, Inc.
 TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ji-Hoon Park via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAUDAX BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Chungnam National University | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 2 |
| Corée du Sud | 2 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Yong-Chan Kim | 3 |
- Bourse
- Insiders
- Ji-Hoon Park
- Connexions Sociétés
